{"id":154,"date":"2019-10-17T17:02:07","date_gmt":"2019-10-17T21:02:07","guid":{"rendered":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/4-4-ans-medication-classes-and-nursing-considerations\/"},"modified":"2022-03-16T12:56:50","modified_gmt":"2022-03-16T16:56:50","slug":"4-5-ans-medication-classes-and-nursing-considerations","status":"publish","type":"chapter","link":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/chapter\/4-5-ans-medication-classes-and-nursing-considerations\/","title":{"raw":"4.5 ANS Medication Classes and Nursing Considerations","rendered":"4.5 ANS Medication Classes and Nursing Considerations"},"content":{"raw":"Classes of medication, categorized according to neuroreceptor, are further discussed in more detail below. Figure 4.5 summarizes how ANS drugs are classified.\r\n\r\n[caption id=\"attachment_1911\" align=\"aligncenter\" width=\"600\"]<img class=\"wp-image-1911 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs.jpg\" alt=\"Graphic flowchart image depicting the classes of drugs acting on the ANS\" width=\"600\" height=\"450\" \/> <em>Figure 4.5 Classification of drugs acting on the ANS<\/em>[\/caption]\r\n\r\nTable 4.5<sup>[footnote]This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">public domain<\/a>[\/footnote]<\/sup> further contrasts agonist and antagonist medications for each ANS neuroreceptor.\r\n<div class=\"textbox textbox--learning-objectives\"><header class=\"textbox__header\">\r\n<h1 class=\"textbox__title\">Table 4.2 Comparison of Prototype Medications that Stimulate Versus Inhibit PNS and SNS Receptors<\/h1>\r\n<\/header>\r\n<div class=\"textbox__content\">\r\n<table class=\"grid\" border=\"0\">\r\n<tbody>\r\n<tr>\r\n<th style=\"width: 161.833px\" scope=\"col\">\r\n<h2><strong>Receptor<\/strong><\/h2>\r\n<\/th>\r\n<th style=\"width: 369.26px\" scope=\"col\">\r\n<h2><strong>Stimulation (Agonist)<\/strong><\/h2>\r\n<\/th>\r\n<th style=\"width: 352.177px\" scope=\"col\">\r\n<h2><strong>Inhibition (Antagonist)<\/strong><\/h2>\r\n<\/th>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Nicotinic<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li>Nicotine is a muscle relaxant with CNS effects.<\/li>\r\n \t<li><a class=\"rId44\" style=\"font-family: inherit;font-size: inherit\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5aadb95f-428c-b637-01f4-50d5866ced0c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Nicotine patch<\/strong><\/a><span style=\"font-family: inherit;font-size: inherit\"> is used for nicotine addiction by slowly reducing dose and avoiding withdrawal effects<\/span><\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li>Not clinically applicable<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Muscarinic<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId45\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fa03947c-6844-45df-aa22-b584c5681269&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pilocarpine <\/strong><\/a>causes muscle contraction; assists with glaucoma by contracting ciliary muscle and draining fluid<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li><a class=\"rId46\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=85225d12-3d96-427a-8027-a4530b8840b0&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Atropine<\/strong><\/a> in small doses inhibits secretions; in moderate doses increases heart rate; in large doses decreases gastrointestinal motility<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Alpha-1\r\n(found in smooth muscles)<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId47\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1056d9da-8a3f-4b7a-878e-7f8d45d298cd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pseudoephedrine<\/strong><\/a> and <a class=\"rId48\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c40df8f6-8374-4f9b-bfce-94d582470d48&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Phenylephrine<\/strong><\/a> cause vasoconstriction, decreased swelling of mucus membranes, and decreased secretions<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li><a class=\"rId49\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Tamsulosin<\/strong><\/a> relaxes smooth muscle in bladder\/prostate to improve urine flow and also decreases blood pressure due to vasodilation<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Alpha-2\r\n(found in brain and periphery)<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId50\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=accb2879-7c0e-40d9-bc78-af78fc619609&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Clonidine<\/strong><\/a> decreases CNS outflow to treat ADHD and also reduces blood pressure and heart rate<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li>Limited clinical use<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Beta-1\r\n(found on heart and kidneys)<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId51\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dobutamine<\/strong><\/a> increases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li><strong>Selective B blocker:<\/strong>\u00a0<a class=\"rId52\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=2d948600-35d8-4490-983b-918bdce488c8&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Metoprolol<\/strong><\/a> works on Beta-1 receptors to decrease blood pressure and heart rate<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Beta-2\r\n(found on the lungs)<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId53\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=808e2b04-9e84-440a-b00e-2cbe858041da&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Albuterol<\/strong><\/a> used for bronchodilation<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li><strong>Nonselective B blocker:<\/strong> <a class=\"rId54\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=179e31a7-9956-4fba-9e9a-2ca28d37d42b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Propranolol<\/strong><\/a> works on Beta-2 and Beta-1 receptors; decreases blood pressure but can also cause bronchoconstriction<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<tr>\r\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Catecholamines stimulate multiple adrenergic receptors<\/strong><\/th>\r\n<td style=\"width: 369.26px\">\r\n<ul>\r\n \t<li><a class=\"rId55\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f03ce427-2dfa-460c-a1a9-c659d7a35b67&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Epinephrine<\/strong><\/a> and <a class=\"rId56\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Norepinephrine<\/strong><\/a>: stimulate alpha-<span style=\"font-family: inherit;font-size: inherit\"> and<\/span> beta-<span style=\"font-family: inherit;font-size: inherit\">receptors on target organs, causing increased heart rate and vasoconstriction for improved blood flow to essential organs<\/span><\/li>\r\n \t<li><a class=\"rId57\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dopamine<\/strong><\/a> has dose-dependent effects that target arteries in the kidneys, heart, and brain<\/li>\r\n<\/ul>\r\n<\/td>\r\n<td style=\"width: 352.177px\">\r\n<ul>\r\n \t<li>Not clinically applicable<\/li>\r\n<\/ul>\r\n<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/div>\r\n<\/div>\r\n<strong style=\"text-align: initial;font-size: 14pt\">Supplementary Videos<\/strong><span style=\"text-align: initial;font-size: 14pt\">:\u00a0 See the supplementary videos below related to sympathetic and parasympathetic nervous system medications.<\/span>\r\n<div class=\"textbox\">\r\n<h3 class=\"video\">Sympathetic Nervous System Drugs<\/h3>\r\n<sup>[footnote]Forciea, B. (2018, January 12). Sympathetic nervous system drugs. [Video]. YouTube. All rights reserved.\u00a0 Video used with permission.\u00a0\u00a0<a href=\"https:\/\/youtu.be\/-e_s-jTPtm4\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/-e_s-jTPtm4<\/a> [\/footnote]<\/sup>\r\n\r\n[embed]https:\/\/www.youtube.com\/embed\/-e_s-jTPtm4[\/embed]\r\n\r\n&nbsp;\r\n<h3 class=\"video\">Parasympathetic Nervous System Drugs<\/h3>\r\n<sup>[footnote]Forciea, B. (2018, February 2). Parasympathetic nervous system drugs. [Video]. YouTube. All rights reserved. Video used with permission.\u00a0<a href=\"https:\/\/youtu.be\/ZSRk_NkbBPg\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/ZSRk_NkbBPg<\/a>[\/footnote]<\/sup>\r\n\r\n[embed]https:\/\/www.youtube.com\/embed\/ZSRk_NkbBPg[\/embed]\r\n\r\n&nbsp;\r\n\r\n<\/div>","rendered":"<p>Classes of medication, categorized according to neuroreceptor, are further discussed in more detail below. Figure 4.5 summarizes how ANS drugs are classified.<\/p>\n<figure id=\"attachment_1911\" aria-describedby=\"caption-attachment-1911\" style=\"width: 600px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-1911 size-full\" src=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs.jpg\" alt=\"Graphic flowchart image depicting the classes of drugs acting on the ANS\" width=\"600\" height=\"450\" srcset=\"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs.jpg 600w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs-300x225.jpg 300w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs-65x49.jpg 65w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs-225x169.jpg 225w, https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-content\/uploads\/sites\/1167\/2019\/10\/ANS-drugs-350x263.jpg 350w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><figcaption id=\"caption-attachment-1911\" class=\"wp-caption-text\"><em>Figure 4.5 Classification of drugs acting on the ANS<\/em><\/figcaption><\/figure>\n<p>Table 4.5<sup><a class=\"footnote\" title=\"This work is a derivative of Daily Med by U.S. National Library of Medicine in the public domain\" id=\"return-footnote-154-1\" href=\"#footnote-154-1\" aria-label=\"Footnote 1\"><sup class=\"footnote\">[1]<\/sup><\/a><\/sup> further contrasts agonist and antagonist medications for each ANS neuroreceptor.<\/p>\n<div class=\"textbox textbox--learning-objectives\">\n<header class=\"textbox__header\">\n<h1 class=\"textbox__title\">Table 4.2 Comparison of Prototype Medications that Stimulate Versus Inhibit PNS and SNS Receptors<\/h1>\n<\/header>\n<div class=\"textbox__content\">\n<table class=\"grid\">\n<tbody>\n<tr>\n<th style=\"width: 161.833px\" scope=\"col\">\n<h2><strong>Receptor<\/strong><\/h2>\n<\/th>\n<th style=\"width: 369.26px\" scope=\"col\">\n<h2><strong>Stimulation (Agonist)<\/strong><\/h2>\n<\/th>\n<th style=\"width: 352.177px\" scope=\"col\">\n<h2><strong>Inhibition (Antagonist)<\/strong><\/h2>\n<\/th>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Nicotinic<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li>Nicotine is a muscle relaxant with CNS effects.<\/li>\n<li><a class=\"rId44\" style=\"font-family: inherit;font-size: inherit\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=5aadb95f-428c-b637-01f4-50d5866ced0c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Nicotine patch<\/strong><\/a><span style=\"font-family: inherit;font-size: inherit\"> is used for nicotine addiction by slowly reducing dose and avoiding withdrawal effects<\/span><\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li>Not clinically applicable<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Muscarinic<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId45\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fa03947c-6844-45df-aa22-b584c5681269&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pilocarpine <\/strong><\/a>causes muscle contraction; assists with glaucoma by contracting ciliary muscle and draining fluid<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li><a class=\"rId46\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=85225d12-3d96-427a-8027-a4530b8840b0&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Atropine<\/strong><\/a> in small doses inhibits secretions; in moderate doses increases heart rate; in large doses decreases gastrointestinal motility<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Alpha-1<br \/>\n(found in smooth muscles)<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId47\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1056d9da-8a3f-4b7a-878e-7f8d45d298cd&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Pseudoephedrine<\/strong><\/a> and <a class=\"rId48\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c40df8f6-8374-4f9b-bfce-94d582470d48&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Phenylephrine<\/strong><\/a> cause vasoconstriction, decreased swelling of mucus membranes, and decreased secretions<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li><a class=\"rId49\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ed9988bc-0759-4c36-bee1-11b68dc1c84c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Tamsulosin<\/strong><\/a> relaxes smooth muscle in bladder\/prostate to improve urine flow and also decreases blood pressure due to vasodilation<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Alpha-2<br \/>\n(found in brain and periphery)<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId50\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=accb2879-7c0e-40d9-bc78-af78fc619609&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Clonidine<\/strong><\/a> decreases CNS outflow to treat ADHD and also reduces blood pressure and heart rate<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li>Limited clinical use<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Beta-1<br \/>\n(found on heart and kidneys)<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId51\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=6b17b98b-e06d-42ed-925f-69aa2699dead&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dobutamine<\/strong><\/a> increases heart rate, force of heart contraction, and speed of conduction between SA to AV nodes<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li><strong>Selective B blocker:<\/strong>\u00a0<a class=\"rId52\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=2d948600-35d8-4490-983b-918bdce488c8&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Metoprolol<\/strong><\/a> works on Beta-1 receptors to decrease blood pressure and heart rate<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Beta-2<br \/>\n(found on the lungs)<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId53\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=808e2b04-9e84-440a-b00e-2cbe858041da&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Albuterol<\/strong><\/a> used for bronchodilation<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li><strong>Nonselective B blocker:<\/strong> <a class=\"rId54\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=179e31a7-9956-4fba-9e9a-2ca28d37d42b&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Propranolol<\/strong><\/a> works on Beta-2 and Beta-1 receptors; decreases blood pressure but can also cause bronchoconstriction<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<tr>\n<th style=\"width: 161.833px;text-align: center\" scope=\"row\"><strong>Catecholamines stimulate multiple adrenergic receptors<\/strong><\/th>\n<td style=\"width: 369.26px\">\n<ul>\n<li><a class=\"rId55\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f03ce427-2dfa-460c-a1a9-c659d7a35b67&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Epinephrine<\/strong><\/a> and <a class=\"rId56\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=a27fb6e0-8f7a-11db-9739-0050c2490048&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Norepinephrine<\/strong><\/a>: stimulate alpha-<span style=\"font-family: inherit;font-size: inherit\"> and<\/span> beta-<span style=\"font-family: inherit;font-size: inherit\">receptors on target organs, causing increased heart rate and vasoconstriction for improved blood flow to essential organs<\/span><\/li>\n<li><a class=\"rId57\" href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=cb97d4a0-89ed-407c-a763-209386b6f75c&amp;audience=consumer\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Dopamine<\/strong><\/a> has dose-dependent effects that target arteries in the kidneys, heart, and brain<\/li>\n<\/ul>\n<\/td>\n<td style=\"width: 352.177px\">\n<ul>\n<li>Not clinically applicable<\/li>\n<\/ul>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p><strong style=\"text-align: initial;font-size: 14pt\">Supplementary Videos<\/strong><span style=\"text-align: initial;font-size: 14pt\">:\u00a0 See the supplementary videos below related to sympathetic and parasympathetic nervous system medications.<\/span><\/p>\n<div class=\"textbox\">\n<h3 class=\"video\">Sympathetic Nervous System Drugs<\/h3>\n<p><sup><a class=\"footnote\" title=\"Forciea, B. (2018, January 12). Sympathetic nervous system drugs. [Video]. YouTube. All rights reserved.\u00a0 Video used with permission.\u00a0\u00a0https:\/\/youtu.be\/-e_s-jTPtm4\" id=\"return-footnote-154-2\" href=\"#footnote-154-2\" aria-label=\"Footnote 2\"><sup class=\"footnote\">[2]<\/sup><\/a><\/sup><\/p>\n<p><iframe loading=\"lazy\" id=\"oembed-1\" title=\"Sympathetic Nervous System  Drugs\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/-e_s-jTPtm4?feature=oembed&#38;rel=0\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<h3 class=\"video\">Parasympathetic Nervous System Drugs<\/h3>\n<p><sup><a class=\"footnote\" title=\"Forciea, B. (2018, February 2). Parasympathetic nervous system drugs. [Video]. YouTube. All rights reserved. Video used with permission.\u00a0https:\/\/youtu.be\/ZSRk_NkbBPg\" id=\"return-footnote-154-3\" href=\"#footnote-154-3\" aria-label=\"Footnote 3\"><sup class=\"footnote\">[3]<\/sup><\/a><\/sup><\/p>\n<p><iframe loading=\"lazy\" id=\"oembed-2\" title=\"Parasympathetic Nervous System Drugs\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/ZSRk_NkbBPg?feature=oembed&#38;rel=0\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<div class=\"media-attributions clear\" prefix:cc=\"http:\/\/creativecommons.org\/ns#\" prefix:dc=\"http:\/\/purl.org\/dc\/terms\/\"><h2>Media Attributions<\/h2><ul><li >ANS drugs       <\/li><\/ul><\/div><hr class=\"before-footnotes clear\" \/><div class=\"footnotes\"><ol><li id=\"footnote-154-1\">This work is a derivative of <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/\" target=\"_blank\" rel=\"noopener noreferrer\">Daily Med<\/a> by <a href=\"https:\/\/www.nlm.nih.gov\/\" target=\"_blank\" rel=\"noopener noreferrer\">U.S. National Library of Medicine<\/a> in the <a href=\"https:\/\/creativecommons.org\/share-your-work\/public-domain\/\" target=\"_blank\" rel=\"noopener noreferrer\">public domain<\/a> <a href=\"#return-footnote-154-1\" class=\"return-footnote\" aria-label=\"Return to footnote 1\">&crarr;<\/a><\/li><li id=\"footnote-154-2\">Forciea, B. (2018, January 12). Sympathetic nervous system drugs. [Video]. YouTube. All rights reserved.\u00a0 Video used with permission.\u00a0\u00a0<a href=\"https:\/\/youtu.be\/-e_s-jTPtm4\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/-e_s-jTPtm4<\/a>  <a href=\"#return-footnote-154-2\" class=\"return-footnote\" aria-label=\"Return to footnote 2\">&crarr;<\/a><\/li><li id=\"footnote-154-3\">Forciea, B. (2018, February 2). Parasympathetic nervous system drugs. [Video]. YouTube. All rights reserved. Video used with permission.\u00a0<a href=\"https:\/\/youtu.be\/ZSRk_NkbBPg\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/youtu.be\/ZSRk_NkbBPg<\/a> <a href=\"#return-footnote-154-3\" class=\"return-footnote\" aria-label=\"Return to footnote 3\">&crarr;<\/a><\/li><\/ol><\/div>","protected":false},"author":103,"menu_order":5,"template":"","meta":{"pb_show_title":"on","pb_short_title":"","pb_subtitle":"","pb_authors":["open-resources-for-nursing-open-rn"],"pb_section_license":""},"chapter-type":[48],"contributor":[68],"license":[],"class_list":["post-154","chapter","type-chapter","status-publish","hentry","chapter-type-numberless","contributor-open-resources-for-nursing-open-rn"],"part":138,"_links":{"self":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/154","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters"}],"about":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/types\/chapter"}],"author":[{"embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/users\/103"}],"version-history":[{"count":9,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/154\/revisions"}],"predecessor-version":[{"id":2616,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/154\/revisions\/2616"}],"part":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/parts\/138"}],"metadata":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapters\/154\/metadata\/"}],"wp:attachment":[{"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/media?parent=154"}],"wp:term":[{"taxonomy":"chapter-type","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/pressbooks\/v2\/chapter-type?post=154"},{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/contributor?post=154"},{"taxonomy":"license","embeddable":true,"href":"https:\/\/pressbooks.bccampus.ca\/nursingpharmacology\/wp-json\/wp\/v2\/license?post=154"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}